PC
Pappas Capital
Venture CapitalActiveBridging the Early-Stage Funding Gap.
15
Investments
6
Exits
$500M
AUM
40.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Pappas Capital.
Investment Thesis & Strategy
Pappas Capital invests in biotech, transportation/logistics, and healthcare companies across various stages, focusing on bridging the early-stage funding gap.
Investment Activity
Deals per year over the last 7 years
1
20150
20163
20174
20182
20191
20201
2021Portfolio Companies
Selected investments from their portfolio of 15 companies
V
Ventyx Biosciences
Biotech · Series A, 2021
D
Disc Medicine
Biotech · Series A, 2020
X
Xilio Therapeutics
Biotech · Series A, 2019
E
Elevation Oncology
Biotech · Series A, 2019
V
Vaxcyte
Biotech · Series A, 2018
C
Cerevel Therapeutics
Biotech · Series A, 2018
T
Tyra Biosciences
Biotech · Series A, 2018
T
Terns Therapeutics
Biotech · Series A, 2018
G
Gossamer Bio
Biotech · Series A, 2017
O
Obsidian Therapeutics
Biotech · Series A, 2017
B
Black Diamond Therapeutics
Biotech · Series A, 2017
R
Revolution Medicines
Biotech · Series A, 2015
Notable Exits
CompanyTypeYearValue / Acquirer
SequellaAcquisition2018—
CoLucid PharmaceuticalsAcquisition2017$900M
Radius HealthIPO2014—
Esperion TherapeuticsIPO2013—
MedicagoAcquisition2013—
Inspire PharmaceuticalsAcquisition2011$430M
Frequently Asked Questions
Pappas Capital focuses on Series A, Series B, Series C+ stage investments.